Dr. Halpern discusses direct-to-consumer testosterone therapy platforms

In this video, Joshua A. Halpern, MD, MS, discusses the background and notable findings from the JAMA Internal Medicine study, “Guideline-Discordant Care Among Direct-to-Consumer Testosterone Therapy Platforms,” for which he served as senior author. Halpern is an assistant professor of urology at Northwestern University Feinberg School of Medicine in Chicago, Illinois.